Phase I, Open-Label Study to Evaluate the Pharmacokinetics, Safety and Tolerability of BIA 28-6156 in Participants with Varying Degrees of Renal Impairment
BIA-28-6156-111
Phase 1 other active
Quick answer
Phase I, Open-Label Study to Evaluate the Pharmacokinetics, Safety and Tolerability of BIA 28-6156 in Participants with Varying Degrees of Renal Impairment for Parkinson's disease is a Phase 1 program (other) at Bial Portela & Companhia S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bial Portela & Companhia S.A.
- Indication
- Parkinson's disease
- Phase
- Phase 1
- Modality
- other
- Status
- active